
483s and Warning Letters Point to Inadequate Quality Oversight
Ajay Pazhayattil is a management consultant. ([email protected]). He has held key management roles with brand name, generic, and contract manufacturing pharmaceutical organizations.

October 2nd 2019

July 2nd 2020